Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating activities
Net loss	$ (5,895,644)	$ (3,364,100)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation	1,712
Accrued interest expense	105,669	$ 329,297
Amortization of deferred financing costs	599,781
Debt discount amortization	449,209	$ 363,543
Stock-based compensation	$ 829,667	148,334
Warrants issued with Line of Credit		520,487
Warrants issued to consultants	$ 324,532	301,833
Loss on sale of marketable securities		$ 9,623
Shares issued for services	$ 1,370,118
Transaction costs financed through notes payable		$ 590,000
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	$ (65,375)	$ 6,768
Deferred financing costs	$ (185,000)
Advances due to related party		$ 98,875
Accounts payable and accrued expenses	$ (69,424)	150,050
Net cash (used in) operating activities	(2,534,755)	$ (845,290)
Investing activities
Purchase of property and equipment	$ (504)
Proceeds from sale of marketable securities		$ 37,377
Net cash (used in) provided by investing activities	$ (504)	37,377
Financing activities
Proceeds from the issuance of common stock		480,000
Repayment of debt		(265,812)
Proceeds from issuance of notes payable - related party		357,200
Proceeds from issuance of notes payable	$ 2,000,000	250,000
Net cash provided by financing activities	2,000,000	821,388
Net increase (decrease) in cash	(535,259)	13,475
Cash, beginning of period	2,661,396	1,538
Cash, end of period	$ 2,126,137	15,013
Supplemental non-cash information
Issuance of warrants in connection with Notes Payable, net of amortization included above		$ 248,744
Related Party Debt and accrued interest converted into Common Shares	$ 3,852,771
Issuance of warrants in payment of financing fees		$ 21,738
Note payable received in the form of investments		$ 50,000
Interest paid	$ 392,943
Taxes paid	$ 8,840	$ 1,600